177 related articles for article (PubMed ID: 7916430)
1. Multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16 or FAB M4Eo subtype.
Zöchbauer S; Haas OA; Schwarzinger I; Lechner K; Pirker R
Lancet; 1994 Sep; 344(8926):894. PubMed ID: 7916430
[No Abstract] [Full Text] [Related]
2. Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications.
Kuss BJ; Deeley RG; Cole SP; Willman CL; Kopecky KJ; Wolman SR; Eyre HJ; Lane SA; Nancarrow JK; Whitmore SA
Lancet; 1994 Jun; 343(8912):1531-4. PubMed ID: 7911871
[TBL] [Abstract][Full Text] [Related]
3. The effect of MDR-1 gene expression on outcome in acute myeloblastic leukaemia.
Holmes JA; West RR
Br J Cancer; 1994 Feb; 69(2):382-4. PubMed ID: 7905280
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance (MDR1) in acute myelogenous leukemia: is it time to test?
Baccarani M; Michieli M; Damiani D; Michelutti A
Blood; 1992 Aug; 80(4):1094-5. PubMed ID: 1353994
[No Abstract] [Full Text] [Related]
5. Failure to detect the P-glycoprotein multidrug resistant phenotype in cases of resistant childhood acute lymphocytic leukaemia.
Ubezio P; Limonta M; D'Incalci M; Damia G; Masera G; Giudici G; Wolverton JS; Beck WT
Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1895-9. PubMed ID: 2576650
[No Abstract] [Full Text] [Related]
6. Multidrug resistance in cancer.
Ferry DR; Kerr DJ
BMJ; 1994 Jan; 308(6922):148-9. PubMed ID: 7906169
[No Abstract] [Full Text] [Related]
7. The biological significance of the multidrug resistance gene MRP in inversion 16 leukemias.
Kuss BJ; Deeley RG; Cole SP; Willman CL; Kopecky KJ; Wolman SR; Eyre HJ; Callen DF
Leuk Lymphoma; 1996 Feb; 20(5-6):357-64. PubMed ID: 8833390
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance: a novel class of membrane-associated transport proteins is identified.
Gros P; Shustik C
Cancer Invest; 1991; 9(5):563-9. PubMed ID: 1682020
[No Abstract] [Full Text] [Related]
9. Biochemistry of multidrug resistance mediated by the multidrug transporter.
Gottesman MM; Pastan I
Annu Rev Biochem; 1993; 62():385-427. PubMed ID: 8102521
[No Abstract] [Full Text] [Related]
10. Genetic aspects of multidrug resistance.
Pauly M; Ries F; Dicato M
Med Oncol Tumor Pharmacother; 1992; 9(1):21-4. PubMed ID: 1364127
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric assessment of multidrug resistance (MDR) phenotype in acute myeloid leukaemia.
Hart SM; Ganeshaguru K; Lyttelton MP; Prentice HG; Hoffbrand AV; Mehta AB
Leuk Lymphoma; 1993 Oct; 11(3-4):239-48. PubMed ID: 7903178
[TBL] [Abstract][Full Text] [Related]
12. Liposomal delivery of antisense oligodeoxynucleotides. Application to the inhibition of the multidrug resistance in cancer cells.
Thierry AR; Dritschilo A
Ann N Y Acad Sci; 1992 Oct; 660():300-2. PubMed ID: 1364094
[No Abstract] [Full Text] [Related]
13. Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia.
Gruber A; Vitols S; Norgren S; Areström I; Peterson C; Björkholm M; Reizenstein P; Luthman H
Br J Cancer; 1992 Aug; 66(2):266-72. PubMed ID: 1380280
[TBL] [Abstract][Full Text] [Related]
14. A gene for a myosin peptide is disrupted by the inv(16)(p13q22) in acute nonlymphocytic leukemia M4Eo.
van der Reijden BA; Dauwerse JG; Wessels JW; Beverstock GC; Hagemeijer A; van Ommen GJ; Breuning MH
Blood; 1993 Nov; 82(10):2948-52. PubMed ID: 8219185
[TBL] [Abstract][Full Text] [Related]
15. MDR1 gene expression in myelodysplastic syndrome and in acute myeloid leukemia evolving from myelodysplastic syndrome.
Zöchbauer S; Gsur A; Götzl M; Wallner J; Lechner K; Pirker R
Anticancer Res; 1994; 14(3B):1293-5. PubMed ID: 7915092
[TBL] [Abstract][Full Text] [Related]
16. Multiple-drug resistance in Ewing's sarcoma and peripheral primitive neuroectodermal tumors.
Triche TJ
Am J Clin Pathol; 1994 Jul; 102(1):1-2. PubMed ID: 7913575
[No Abstract] [Full Text] [Related]
17. Current status and future directions of research on multidrug resistance. The impact of contemporary biotechnology.
Mickisch GH
Urol Res; 1993 Mar; 21(2):79-81. PubMed ID: 8099243
[No Abstract] [Full Text] [Related]
18. [Multidrug resistance induced by surexpression of the mdrl gene].
Guerci AP
Rev Med Interne; 1993; 14(8):772-9. PubMed ID: 7910697
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein expression in refractory hematological neoplasms and circumvention of resistance with verapamil or cyclosporine A containing protocols.
Beksaç M; Akan H; Koç H; Ilhan O; Ertürk S; Güneyli A; Ikizünal Y; Sardaş OS
Med Oncol Tumor Pharmacother; 1992; 9(2):101-5. PubMed ID: 1364132
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance (MDR) gene expression in acute non lymphoblastic leukemia: sequential analysis.
Marie JP; Legrand O; Russo D; Zhou D; Suberville AM; Zittoun R
Leuk Lymphoma; 1992 Nov; 8(4-5):261-5. PubMed ID: 1363283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
